Mallinckrodt Announces Encouraging Interim Analysis Results in Phase 4 Registry of INOmax(R) (Nitric Oxide) Gas for Inhalation for Pulmonary Hypertension in Neonates

Observational registry (at midway point) with retrospective data collection provides preliminary evaluation of premature versus term and near-term neonates with pulmonary hypertension receiving inhaled nitric oxide STAINES-UPON-THAMES, United Kingdom, M... Biopharmaceuticals Mallinckrodt, INOmax, nitric oxide, pulmonary hypertension
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news